Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Intraoperative Indocyanine Green Arteriography in Preserving Parathyroid Glands During Total Thyroidectomy
2023-509130-18-00Phase 3Authorised
- Sponsor
- Bellvitge University Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of indocyanine green in thyroid disease (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Parathyroid glands preserved with vs without intraoperative ICG arteriography. Planned start Jan 2024; status: authorised.
02
Drugs
indocyanine green
03
Conditions
thyroid disease
Beyond the preview
Go deeper on 2023-509130-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509130-18-00.